1 Min Read
* Portola Pharmaceuticals announces proposed offering of common stock
* Portola Pharmaceuticals Inc says plans to offer, $300 million of its common stock in an underwritten public offering Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.